PALATIN TECHNOLOGIES, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $16.13K.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, stock options exercised for the quarter ending 2018-06-30 was $2.48M.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $16.13K.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $808.93K, a 67.78% decline from fiscal 2018.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, stock options exercised for fiscal 2018 was $2.51M, a 1427.78% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $16.13K 10-K · filed 2023-09-28 |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | |
| 2021-12-31 | $16.13K 10-Q · filed 2023-02-14 | |
| 2020-06-30 | $0.00 10-K · filed 2020-09-25 | |
| 2019-06-30 | $808.93K 10-K · filed 2020-09-25 | |
| 2018-06-30 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | $2.51M 10-K · filed 2020-09-25 |
| 2018-03-31 | $31.23K 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $0.00 10-Q · filed 2019-02-11 | |
| 2017-09-30 | $114.38K 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $164.36K 10-K · filed 2019-09-12 | |
| 2015-06-30 | $254.15K 10-K · filed 2017-09-25 | |
| 2010-06-30 | $11.44K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |